title: Use of Thrombopoietin-Receptor Agonist in CVID-Associated Immune Thrombocytopenia.
authors.affiliation: Department of Internal Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Padiglione Granelli, Via F. Sforza 35, 20122, Milan, Italy.
authors.forename: Maria
authors.initials: M
authors.lastname: Carrabba
authors.affiliation: UOC Oncoematologia, UOS Fisiopatologia delle Anemie, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
authors.forename: Wilma
authors.initials: W
authors.lastname: Barcellini
authors.affiliation: Department of Internal Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Padiglione Granelli, Via F. Sforza 35, 20122, Milan, Italy. giovanna.fabio@unimi.it.|Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy. giovanna.fabio@unimi.it.
authors.forename: Giovanna
authors.initials: G
authors.lastname: Fabio
mesh_terms: D000328:Adult; D001565:Benzoates / Q000627:therapeutic use*; D017074:Common Variable Immunodeficiency / Q000150:complications* / Q000175:diagnosis / Q000276:immunology; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D011720:Pyrazoles / Q000627:therapeutic use*; D053628:Receptors, Thrombopoietin / Q000819:agonists*
chemical_list: D001565:Benzoates; D006834:Hydrazines; D011720:Pyrazoles; D053628:Receptors, Thrombopoietin; C520809:eltrombopag